Epilepsy Trial, Recruiting (NCT06814665)

Epilepsy Trial, Recruiting NCT06814665 Sponsor: Haukeland University Hospital Condition: Epilepsy

Printed from Voxsanity (voxsanity.com.au) — NCT06814665 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Epilepsy

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You have had one or more events in your life that are strongly suspected to be epileptic seizures (including seizures caused by fever), and these have never been assessed by a neurologist or pediatrician before.
You have had events suspected to be epileptic seizures that a neurologist or pediatrician previously said were not epileptic, but the events have happened again and a new assessment is now needed.
You were investigated for unusual episodes or symptoms, and after evaluation it was confirmed these were your first-ever epileptic seizures.

Who may not be able to join:

You have already been formally diagnosed with epilepsy by a neurologist or pediatrician, and that diagnosis has not been taken back or overturned.
You (or your caregiver, if applicable) are not able to give informed consent to take part in the study (confirm with trial site).
You do not have a good enough level of Norwegian language skills to complete the study questionnaires.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 23 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Jan Brogger, MD PhD, Helse-Bergen HF

Phone: 4755975058

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT06814665

Sponsor: Haukeland University Hospital

Phase: Not Applicable

Status: Recruiting

Condition: Epilepsy

Trial contact: 4755975058

More information: https://clinicaltrials.gov/study/NCT06814665

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You have had one or more events in your life that are strongly suspected to be epileptic seizures (including seizures caused by fever), and these have never been assessed by a neurologist or pediatrician before.
You have had events suspected to be epileptic seizures that a neurologist or pediatrician previously said were not epileptic, but the events have happened again and a new assessment is now needed.
You were investigated for unusual episodes or symptoms, and after evaluation it was confirmed these were your first-ever epileptic seizures.

Who may not be able to join:

You have already been formally diagnosed with epilepsy by a neurologist or pediatrician, and that diagnosis has not been taken back or overturned.
You (or your caregiver, if applicable) are not able to give informed consent to take part in the study (confirm with trial site).
You do not have a good enough level of Norwegian language skills to complete the study questionnaires.

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 23 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Haukeland University Hospital

Registry

ClinicalTrials.gov

Start date

24 January 2025

Est. completion

24 January 2027

Where this trial is recruiting

🇳🇴 Norway

Primary endpoints

Incidence of first seizure and new-onset epilepsy; Percent diagnostic EEG; Sensitivity, specificity, accuracy of human vs human-AI-assisted EEG analysis to predict future epilepsy; Seizure control in new-onset epilepsy; Seizure-related trauma; Loss of driving license; Loss of labor market participation; New-onset psychiatric diagnoses

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov